Table 2.
Outcomes | SBP due to | P-value | |
---|---|---|---|
ESBL-EK (n = 26) | Non-ESBL-EK (n = 78) | ||
Initial response† | |||
Complete response (n, %) | 2 (8%) | 28 (36%) | < 0.001 |
Treatment failure (n, %) | 15 (58%) | 10 (13%) | 0.006 |
7-day mortality (n, %) | 9 (35%) | 3 (4%) | < 0.001 |
30-day mortality (n, %) | 12 (46%) | 11 (14%) | 0.001 |
† Initial response was assessed 72 hours after the initiation of empirical treatment